Spondyloarthropathies News

The patient-reported impact of axial spondyloarthritis on work productivity is greater rural areas than in cities, according to data published in the Annals of the Rheumatic Diseases.

Patients with fibromyalgia, osteoarthritis or rheumatoid arthritis are at an increased risk for self-harm, compared with those without these diseases, according to findings published in Arthritis Care & Research.

A U.S. appeals court has ruled in favor of two patents for Amgen’s etanercept against the biosimilar etanercept-szzs from Novartis’ Sandoz, upholding a prior decision validating claims of patent infringement.

The time a person with ankylosing spondylitis spends undiagnosed can negatively impact quality of life.

While rheumatic diseases like ankylosing spondylitis confound clinicians, tumor necrosis factor inhibitors have shown consistent efficacy and safety to be a reliable tool for rheumatologists in this patient population.

Treatment with IL-17 inhibitors significantly increases response rates among patients with ankylosing spondylitis, but with an increased risk for non-severe infections, according to a meta-analysis published in Arthritis Research & Therapy.

The use of TNF inhibitors among patients with autoimmune disease may be associated with an increased risk for inflammatory central nervous system events, according to data published in JAMA Neurology.

Women aged 18 to 45 years with rheumatic diseases want rheumatologists to play an active role in their sexual and reproductive health, according to findings from a series of interviews published in Arthritis Care & Research.

Patients with rheumatic diseases plus COVID-19 are more likely to require mechanical ventilation, but demonstrated similar clinical features and hospitalization rates as those with COVID-19 only, according to data published in the Annals of the Rheumatic Diseases.

The FDA has expanded the approval of secukinumab to include treatment of active nonradiographic axial spondyloarthritis, allowing this drug to treat patients across the entire axSpA spectrum.